Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06037421 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Metagenomic Analysis of Bacterial Microbiota in Breast Milk

Study acronym: MIC-LAMA2
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv9
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jun 1, 2028 to Dec 31, 2028
    • Start date: Nov 1, 2025 to Sep 8, 2025
    • Site details revised
    v8
  3. Start date: Apr 1, 2025 to Nov 1, 2025
    • Primary completion date: Dec 31, 2027 to Jun 1, 2028
    • Study completion date: Nov 1, 2028 to Jun 1, 2028
    v7
  4. Start date: Jan 1, 2025 to Apr 1, 2025
    • Trial status: Recruiting to Not Yet Recruiting
    • Site details revised
    v6
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Sep 1, 2024 to Jan 1, 2025
    • Primary completion date: Nov 1, 2028 to Dec 31, 2027
    • Site details revised
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: Mar 1, 2028 to Nov 1, 2028
    • Start date: Feb 1, 2024 to Sep 1, 2024
    v4
  2. Start date: Oct 15, 2023 to Feb 1, 2024
    • Primary and study completion dates: Nov 15, 2027 to Mar 1, 2028
    v3
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to determine the extent to which bacteria in the breast milk microbiota represent an infectious risk for premature infants, by investigating whether they possess virulence genes, and if so, whether these are expressed or repressed.
Trial Details
NCT Number NCT06037421
Lead Sponsor Centre Hospitalier Sud Francilien
Conditions
(from sponsor)		 Bacteria in Breast Milk
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov